**PURPOSE:** Chronic wounds of the lower extremity pose a number of challenges for management by surgeons. Nonhealing, infected, or otherwise complicated wounds may fail local wound care, often leading to amputation. Historically, there has been a debate regarding limb salvage microsurgical free tissue transfer (FTT) versus amputation. When utilized appropriately, lower extremity microsurgical FTT can lead to successful limb salvage in a majority of patients. Limb salvage, as opposed to amputation, can have a profound impact on quality of life, independence, and mortality. However, limb salvage requires costly multidisciplinary care that becomes increasingly expensive if there is flap failure, necessitating a return to the operating room. Identifying independent risk factors for amputation following FTT can help in the decision-making process.

**METHODS:** A retrospective chart review identified all patients undergoing FTT to the lower extremity by the senior author (K.K.E.) between 2011 and 2018. One hundred thirty-five patients were included in the study, of which 117 patients (86.7%) had successful limb salvage and 18 patients (13.3%) received an amputation following FTT. Data collected included patient demographics, medical comorbidities, wound location, lower extremity angiography, and type of free flap.

**RESULTS:** Twelve men (66.7%) and 6 women (33.3%) underwent amputation following FTT, whereas 81 men (69.2%) and 35 women (29.9%) had successful limb salvage following FTT. Demographics between the groups were similar, including age (amputation: 54.3 ± 11.1, limb salvage: 54.7 ± 14.6; *P* = 0.8981) and body mass index (amputation: 29.2 ± 5.8; limb salvage: 26.8 ± 3.6; *P* = 0.0911). The most common comorbid conditions were hypertension (50.4%), diabetes mellitus (47.4%), and peripheral vascular disease (23.0%), and the most commonly utilized flap was the anterolateral thigh flap (53.3%). On univariate analysis, diabetes mellitus was associated with a 3.79 times increase in the risk of undergoing amputation following FTT (*P* = 0.0097; odds ratio \[OR\], 3.79; 1.05--13.75) and a 20 times increase with end-stage renal disease (*P* = 0.0074; OR, 20.0; 1.95--204.96). Additional factors that increased the risk for amputation were hindfoot wound location (*P* = 0.0006; OR, 6.51; 2.02--20.94), elevated pre-FTT HbA1c levels (amputation: 8.4 ± 2.4; limb salvage: 7.0 ± 1.8; OR, 1.41; 1.004--1.99; *P* = 0.0451), and higher pre-FTT platelet count (amputation: 332.8 ± 114.4; limb salvage: 257.8 ± 78.7; OR, 1.01; 1.001--1.02; *P* = 0.0100). Interestingly, patients receiving a gracilis flap had a 6.93 times increased likelihood of undergoing amputation (*P* = 0.0283; OR, 6.93; 1.55--30.89).

**CONCLUSION:** Many previous studies on this topic have centered on flap outcomes, success rates, and overall limb salvage rates. This is the largest series to report risk factors for amputation following FTT for limb-threatening defects. Our study finds that there are distinct risk factors that are associated with increased risk for amputation following FTT to the lower extremity. Poorly controlled diabetes mellitus and end-stage renal disease are associated with higher likelihood of amputation. Other factors, such as hindfoot wound location and gracilis flap reconstruction, also have a higher likelihood of requiring amputation. These findings may aide surgeons in choosing appropriate patients for FTT and predict those that are more likely to need amputation. Further evaluation with multi-institutional data may identify additional risk factors.
